Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study.
Identifieur interne : 000380 ( Main/Corpus ); précédent : 000379; suivant : 000381Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study.
Auteurs : Darren Lau ; Dean T. Eurich ; Sumit R. Majumdar ; Alan Katz ; Jeffrey A. JohnsonSource :
- Thorax [ 1468-3296 ] ; 2013.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Diabetes Mellitus (epidemiology), Female (MeSH), Follow-Up Studies (MeSH), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (complications), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male (MeSH), Manitoba (epidemiology), Middle Aged (MeSH), Morbidity (trends), Population Surveillance (methods), Prognosis (MeSH), Retrospective Studies (MeSH), Survival Rate (trends), Time Factors (MeSH), Vaccination (methods), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Manitoba.
- complications : Influenza, Human.
- epidemiology : Diabetes Mellitus, Influenza, Human.
- methods : Population Surveillance, Vaccination.
- prevention & control : Influenza, Human.
- trends : Morbidity, Survival Rate.
- Adolescent, Adult, Aged, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Time Factors, Young Adult.
Abstract
BACKGROUND
Guidelines recommend influenza vaccinations in all diabetic adults, but there is limited evidence to support vaccinating working-age adults (<65 years) with diabetes. We examined the effectiveness of influenza vaccine in this subgroup, compared with elderly adults (≥ 65 years) for whom vaccination recommendations are well accepted.
METHODS
We identified all adults with diabetes, along with a sample of age-matched and sex-matched comparison subjects without diabetes, from 2000 to 2008, using administrative data from Manitoba, Canada. With multivariable Poisson regression, we estimated vaccine effectiveness (VE) on influenza-like illnesses (ILIs), pneumonia and influenza (PI) hospitalisations and all-cause (ALL) hospitalisations during periods of known circulating influenza. Analyses were replicated outside of influenza season to rule out residual confounding.
RESULTS
We included 543 367 person-years of follow-up, during which 223 920 ILI, 5422 PI and 94 988 ALL occurred. The majority (58%) of adults with diabetes were working age. In this group, influenza vaccination was associated with relative reductions in PI (43%, 95% CI 28% to 54%) and ALL (28%, 95% CI 24% to 32%) but not ILI (-1%, 95% CI -3% to 1%). VE was similar in elderly adults for ALL (33-34%) and PI (45-55%), although not ILI (12-13%). However, similar estimates of effectiveness were also observed for all three groups during non-influenza control periods.
CONCLUSIONS
Working-age adults with diabetes experience similar benefits from vaccination as elderly adults, supporting current diabetes-specific recommendations. However, these benefits were also manifest outside of influenza season, suggesting residual bias. Vaccination recommendations in all high-risk adults would benefit from randomised trial evidence.
DOI: 10.1136/thoraxjnl-2012-203109
PubMed: 23535212
PubMed Central: PMC3711373
Links to Exploration step
pubmed:23535212Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study.</title>
<author><name sortKey="Lau, Darren" sort="Lau, Darren" uniqKey="Lau D" first="Darren" last="Lau">Darren Lau</name>
<affiliation><nlm:affiliation>Department of Public Health Sciences, University of Alberta, Edmonton, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Eurich, Dean T" sort="Eurich, Dean T" uniqKey="Eurich D" first="Dean T" last="Eurich">Dean T. Eurich</name>
</author>
<author><name sortKey="Majumdar, Sumit R" sort="Majumdar, Sumit R" uniqKey="Majumdar S" first="Sumit R" last="Majumdar">Sumit R. Majumdar</name>
</author>
<author><name sortKey="Katz, Alan" sort="Katz, Alan" uniqKey="Katz A" first="Alan" last="Katz">Alan Katz</name>
</author>
<author><name sortKey="Johnson, Jeffrey A" sort="Johnson, Jeffrey A" uniqKey="Johnson J" first="Jeffrey A" last="Johnson">Jeffrey A. Johnson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23535212</idno>
<idno type="pmid">23535212</idno>
<idno type="doi">10.1136/thoraxjnl-2012-203109</idno>
<idno type="pmc">PMC3711373</idno>
<idno type="wicri:Area/Main/Corpus">000380</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000380</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study.</title>
<author><name sortKey="Lau, Darren" sort="Lau, Darren" uniqKey="Lau D" first="Darren" last="Lau">Darren Lau</name>
<affiliation><nlm:affiliation>Department of Public Health Sciences, University of Alberta, Edmonton, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Eurich, Dean T" sort="Eurich, Dean T" uniqKey="Eurich D" first="Dean T" last="Eurich">Dean T. Eurich</name>
</author>
<author><name sortKey="Majumdar, Sumit R" sort="Majumdar, Sumit R" uniqKey="Majumdar S" first="Sumit R" last="Majumdar">Sumit R. Majumdar</name>
</author>
<author><name sortKey="Katz, Alan" sort="Katz, Alan" uniqKey="Katz A" first="Alan" last="Katz">Alan Katz</name>
</author>
<author><name sortKey="Johnson, Jeffrey A" sort="Johnson, Jeffrey A" uniqKey="Johnson J" first="Jeffrey A" last="Johnson">Jeffrey A. Johnson</name>
</author>
</analytic>
<series><title level="j">Thorax</title>
<idno type="eISSN">1468-3296</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Diabetes Mellitus (epidemiology)</term>
<term>Female (MeSH)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Male (MeSH)</term>
<term>Manitoba (epidemiology)</term>
<term>Middle Aged (MeSH)</term>
<term>Morbidity (trends)</term>
<term>Population Surveillance (methods)</term>
<term>Prognosis (MeSH)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Survival Rate (trends)</term>
<term>Time Factors (MeSH)</term>
<term>Vaccination (methods)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Manitoba</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Diabetes Mellitus</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Population Surveillance</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Morbidity</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>Guidelines recommend influenza vaccinations in all diabetic adults, but there is limited evidence to support vaccinating working-age adults (<65 years) with diabetes. We examined the effectiveness of influenza vaccine in this subgroup, compared with elderly adults (≥ 65 years) for whom vaccination recommendations are well accepted.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>We identified all adults with diabetes, along with a sample of age-matched and sex-matched comparison subjects without diabetes, from 2000 to 2008, using administrative data from Manitoba, Canada. With multivariable Poisson regression, we estimated vaccine effectiveness (VE) on influenza-like illnesses (ILIs), pneumonia and influenza (PI) hospitalisations and all-cause (ALL) hospitalisations during periods of known circulating influenza. Analyses were replicated outside of influenza season to rule out residual confounding.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>We included 543 367 person-years of follow-up, during which 223 920 ILI, 5422 PI and 94 988 ALL occurred. The majority (58%) of adults with diabetes were working age. In this group, influenza vaccination was associated with relative reductions in PI (43%, 95% CI 28% to 54%) and ALL (28%, 95% CI 24% to 32%) but not ILI (-1%, 95% CI -3% to 1%). VE was similar in elderly adults for ALL (33-34%) and PI (45-55%), although not ILI (12-13%). However, similar estimates of effectiveness were also observed for all three groups during non-influenza control periods.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>Working-age adults with diabetes experience similar benefits from vaccination as elderly adults, supporting current diabetes-specific recommendations. However, these benefits were also manifest outside of influenza season, suggesting residual bias. Vaccination recommendations in all high-risk adults would benefit from randomised trial evidence.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23535212</PMID>
<DateCompleted><Year>2013</Year>
<Month>09</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-3296</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>68</Volume>
<Issue>7</Issue>
<PubDate><Year>2013</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Thorax</Title>
<ISOAbbreviation>Thorax</ISOAbbreviation>
</Journal>
<ArticleTitle>Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study.</ArticleTitle>
<Pagination><MedlinePgn>658-63</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/thoraxjnl-2012-203109</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Guidelines recommend influenza vaccinations in all diabetic adults, but there is limited evidence to support vaccinating working-age adults (<65 years) with diabetes. We examined the effectiveness of influenza vaccine in this subgroup, compared with elderly adults (≥ 65 years) for whom vaccination recommendations are well accepted.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We identified all adults with diabetes, along with a sample of age-matched and sex-matched comparison subjects without diabetes, from 2000 to 2008, using administrative data from Manitoba, Canada. With multivariable Poisson regression, we estimated vaccine effectiveness (VE) on influenza-like illnesses (ILIs), pneumonia and influenza (PI) hospitalisations and all-cause (ALL) hospitalisations during periods of known circulating influenza. Analyses were replicated outside of influenza season to rule out residual confounding.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 543 367 person-years of follow-up, during which 223 920 ILI, 5422 PI and 94 988 ALL occurred. The majority (58%) of adults with diabetes were working age. In this group, influenza vaccination was associated with relative reductions in PI (43%, 95% CI 28% to 54%) and ALL (28%, 95% CI 24% to 32%) but not ILI (-1%, 95% CI -3% to 1%). VE was similar in elderly adults for ALL (33-34%) and PI (45-55%), although not ILI (12-13%). However, similar estimates of effectiveness were also observed for all three groups during non-influenza control periods.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Working-age adults with diabetes experience similar benefits from vaccination as elderly adults, supporting current diabetes-specific recommendations. However, these benefits were also manifest outside of influenza season, suggesting residual bias. Vaccination recommendations in all high-risk adults would benefit from randomised trial evidence.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lau</LastName>
<ForeName>Darren</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Public Health Sciences, University of Alberta, Edmonton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Eurich</LastName>
<ForeName>Dean T</ForeName>
<Initials>DT</Initials>
</Author>
<Author ValidYN="Y"><LastName>Majumdar</LastName>
<ForeName>Sumit R</ForeName>
<Initials>SR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Katz</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Johnson</LastName>
<ForeName>Jeffrey A</ForeName>
<Initials>JA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>03</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Thorax</MedlineTA>
<NlmUniqueID>0417353</NlmUniqueID>
<ISSNLinking>0040-6376</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008350" MajorTopicYN="N" Type="Geographic">Manitoba</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Epidemiology</Keyword>
<Keyword MajorTopicYN="N">Viral infection</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>9</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23535212</ArticleId>
<ArticleId IdType="pii">thoraxjnl-2012-203109</ArticleId>
<ArticleId IdType="doi">10.1136/thoraxjnl-2012-203109</ArticleId>
<ArticleId IdType="pmc">PMC3711373</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Int J Epidemiol. 2006 Apr;35(2):337-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16368725</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2006 Aug;29(8):1771-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16873778</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2006 Oct 28;333(7574):912-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17068038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2007 Oct 4;357(14):1373-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17914038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2007 Oct 6;370(9594):1199-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17897708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2008 Aug 26;26(36):4697-703</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18620016</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2008 Sep 1;178(5):527-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18556629</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2009 Jan;32 Suppl 1:S13-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19118286</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2008 Jan;2(1):1-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19453488</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Epidemiol. 2009 Jul;62(7):687-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19124221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2009 Oct 23;27(45):6300-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19840664</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2010 Apr;7(4):e1000256</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20386727</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20689501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2010 Sep 8;304(10):1091-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20823435</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011;6(7):e22618</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21818350</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2000 Jan;23(1):95-108</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10857977</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Care. 2001 Jan;39(1):86-99</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11176546</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Intern Med. 2001 Dec 10-24;161(22):2702-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11732935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc AMIA Symp. 2001;:711-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11825278</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2002 Aug 15;35(4):370-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12145718</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2004 Feb;27(2):407-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14747221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2004 Sep 15;292(11):1333-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15367555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2004 Nov;27(11):2581-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15504989</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Public Health. 1992 May;82(5):703-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1566949</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 1996 Aug;19(8):807-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8842595</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 1997 Dec;119(3):335-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9440437</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 1999 Mar 10;281(10):901-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10078486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prev Med. 2005 Feb;40(2):152-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15533524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2005 Oct 1;366(9492):1165-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16198765</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Epidemiol. 2006 Apr;35(2):345-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16368724</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000380 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000380 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeCanadaV4 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:23535212 |texte= Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:23535212" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a GrippeCanadaV4
This area was generated with Dilib version V0.6.35. |